Why the study?
Does a physician-pharmacist collaborative intervention reduce mean systolic blood pressure and improve blood pressure control in patients with uncontrolled hypertension and diabetes and/or chronic kidney disease?
Does a physician-pharmacist collaborative intervention reduce mean systolic blood pressure and improve blood pressure control in patients with uncontrolled hypertension and diabetes and/or chronic kidney disease?
Answers are grounded in this paper and cite their sources.
A physician-pharmacist collaborative intervention effectively improves blood pressure control in high-risk patients with uncontrolled hypertension and comorbidities like diabetes or chronic kidney disease.
This study demonstrated that a physician-pharmacist collaborative intervention was effective in reducing mean systolic BP and improving BP control in patients with uncontrolled hypertension with DM and/or CKD, regardless of which BP guidelines were used.
No takes yet. Share an insight, caveat, or question.
Anderegg et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: